Literature DB >> 20539244

Influence of loss of function MC1R variants in genetic susceptibility of familial melanoma in Spain.

Carlos de Torre1, Zaida Garcia-Casado, Jorge A Martínez-Escribano, Rafael Botella-Estrada, Jose Bañuls, Vicente Oliver, Pedro Mercader, Jose M Azaña, Javier Frias, Eduardo Nagore.   

Abstract

We explored the presence of germline alterations in CDK4 exon 2, CDKN2A and MC1R in a hospital-based study of 89 melanoma cases from 89 families with at least two members affected by cutaneous melanoma. A total of 30% of the melanoma kindreds studied were carriers of CDKN2A variants, and three of these variants were known predominant alleles that have been identified earlier in Mediterranean populations (p.G101W, p.V59G and c.358delG). We observed a higher frequency of nonsynonymous MC1R variants in these Spanish melanoma kindreds (72%) with respect to the general population (60%). We observed a higher frequency of nonsynonymous MC1R variants in this Spanish melanoma kindred (72%) respect to general population (60%). A new classification of MC1R variants based on their functional effects over melanocortin-1 receptor, including the dominant-negative effect of some of them in heterozygotes, suggested an association of loss of function MC1R variants and multiple primary melanoma cases from melanoma kindred (odds ratio: 6.07, 95% confidence interval: 1.35-27.20). This study proposes the relevance of loss of function MC1R variants in the risk of melanoma in multiple primary melanoma cases with family history from areas with low melanoma incidence rate.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20539244     DOI: 10.1097/CMR.0b013e32833b159d

Source DB:  PubMed          Journal:  Melanoma Res        ISSN: 0960-8931            Impact factor:   3.599


  6 in total

1.  Characterization of melanoma susceptibility genes in high-risk patients from Central Italy.

Authors:  Cristina Pellegrini; Maria Giovanna Maturo; Claudia Martorelli; Mariano Suppa; Ambra Antonini; Dimitra Kostaki; Lucilla Verna; Maria Teresa Landi; Ketty Peris; Maria Concetta Fargnoli
Journal:  Melanoma Res       Date:  2017-06       Impact factor: 3.599

Review 2.  A review of common tanning methods.

Authors:  Michael Garone; John Howard; Jordan Fabrikant
Journal:  J Clin Aesthet Dermatol       Date:  2015-02

Review 3.  Update in genetic susceptibility in melanoma.

Authors:  Miriam Potrony; Celia Badenas; Paula Aguilera; Joan Anton Puig-Butille; Cristina Carrera; Josep Malvehy; Susana Puig
Journal:  Ann Transl Med       Date:  2015-09

4.  Interest and Uptake of MC1R Testing for Melanoma Risk in a Diverse Primary Care Population: A Randomized Clinical Trial.

Authors:  Jennifer L Hay; Kate Zielaskowski; Kirsten Meyer White; Kimberly Kaphingst; Erika Robers; Dolores Guest; Andrew Sussman; Yvonne Talamantes; Matthew Schwartz; Vivian M Rodríguez; Yuelin Li; Elizabeth Schofield; Jessica Bigney; Keith Hunley; David Buller; Marianne Berwick
Journal:  JAMA Dermatol       Date:  2018-06-01       Impact factor: 10.282

5.  Implementing an Internet-Delivered Skin Cancer Genetic Testing Intervention to Improve Sun Protection Behavior in a Diverse Population: Protocol for a Randomized Controlled Trial.

Authors:  Jennifer L Hay; Marianne Berwick; Kate Zielaskowski; Kirsten Am White; Vivian M Rodríguez; Erika Robers; Dolores D Guest; Andrew Sussman; Yvonne Talamantes; Matthew R Schwartz; Jennie Greb; Jessica Bigney; Kimberly A Kaphingst; Keith Hunley; David B Buller
Journal:  JMIR Res Protoc       Date:  2017-04-25

6.  Inherited MC1R variants in patients with melanoma are associated with better survival in women.

Authors:  F E Lira; S Podlipnik; M Potrony; G Tell-Martí; N Calbet-Llopart; A Barreiro; C Carrera; J Malvehy; S Puig
Journal:  Br J Dermatol       Date:  2019-05-13       Impact factor: 9.302

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.